Mesothelioma Treatment
Mesothelioma Cancer
- Causes of Mesothelioma
- Mesothelioma Symptoms
- Mesothelioma Diagnosis
- Mesothelioma Stages
- Mesothelioma Treatment
- Innovative Mesothelioma Treatments
- Managing Mesothelioma Pain
- Nutrition Information for Mesothelioma Patients
- Specialized Mesothelioma Care
- Mesothelioma Risks
- Mesothelioma Support Groups
- Find a Mesothelioma Attorney
- Mesothelioma News
Mesothelioma Directory
Molecular Predictors of Pemetrexed and Carboplatin Response in Tumor Samples of a Series of Malignant Pleural Mesothelioma (MPM) Patients and Genotyping for the TSER Polymorphism
Get Help Today
Looking for help or additional information? Contact us today.| Conditions: | Malignant Pleural Mesothelioma |
| Start Date: | January 1, 2009 |
| Phase: | |
| Status: | Active, not recruiting |
| NCT ID: | NCT00867711 |
| Study Type: | Observational |
| Intervention: | |
| Study Design: | Cohort/Retrospective |
| Results: | No Results Available |
| Sponsors: | Istituto Clinico Humanitas |
| Ages: | Adult/Senior |
| Enrollment: | 100 |
| Funded By: | OTHER |
| First Received: | March 23, 2009 |
| End Date: | September 1, 2009 |
| Last Updated: | April 1, 2009 |
| Last Verified: | March 1, 2009 |